心脏性休克和慢性病:危险的联系人
Miloud Cherbi1, Eric Bonnefoy2, Etienne Puymirat3
1Intensive Cardiac Care Unit, Rangueil University Hospital, 31059 Toulouse, France; Institute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1048, National Institute of Health and Medical Research (Inserm), 31059 Toulouse, France.
Archives of cardiovascular diseases
|April 9, 2024
概括
患有慢性病 (CKD) 经历心脏性休克的患者面临的死亡率明显更高. 置换疗法 (RRT) 进一步增加死亡风险,强调需要综合护理.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 临界护理医学 临界护理医学
背景情况:
- 慢性病 (CKD) 是一个主要的全球健康问题,与心血管疾病密切相关,通常导致心脏综合征.
- 慢性病患者心脏性休克 (CS) 尚未得到充分研究,尽管它具有关键的含义.
研究的目的:
- 研究患有和没有慢性病的患者心脏性休克的结果.
- 确定与CKD患者中CS相关的风险因素和治疗模式.
主要方法:
- 该研究使用了来自前FRENSHOCK注册表 (NCT02703038) 的数据,涉及49个中心772名患者.
- 根据入院时的CKD存在情况分析了一年的结果,并根据独立预测因素进行调整.
主要成果:
- 21.3%的CS患者患有CKD;他们年龄较大,并有更多的并发症.
- 慢性病与1个月 (36.6%对23.2%) 和1年 (62.8%对40.5%) 的全因死亡率显著上升.
- 慢性病患者接受的内类/血管压缩剂支持和机械支持较少,但更多的代疗法 (RRT),独立预测更高的死亡率.
结论:
- 心脏性休克和CKD是非常普遍的疾病,治疗选择有限,导致死亡率增加.
- 替代疗法 (RRT) 是CS患者死亡的重要预测因素,无论基线CKD状态如何.
- 涉及多学科心脏和脏专家团队的综合护理对于管理心脏脏综合征至关重要.
相关概念视频
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K


